✦ LIBER ✦

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

✍ Scribed by Paul M Ridker; Eleanor Danielson; Francisco AH Fonseca; Jacques Genest; Antonio M Gotto Jr; John JP Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn

Book ID: 117304502
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 212 KB
Volume: 373
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(09)60447-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence and Critique of the JUPITER Tr

Influence and Critique of the JUPITER Trial (Statins v No Statins for Primary Prevention of Cardiovascular Events in Patients with Normal Lipids and Elevated C-Reactive Protein)

✍ Russell H. Samson; Deepak G. Nair 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Efficacy of Rosuvastatin Among Men and W

Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein: A Secondary Analysis From the JUPITER (Justification for the Use of Statins in Prevention–an Intervention Trial Evaluating Rosuvastatin) Trial

✍ Paul M. Ridker; Jean MacFadyen; Michael Cressman; Robert J. Glynn 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Further reduction of low-density lipopro

Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia

✍ Evan A. Stein; Leiv Ose; Kjetil Retterstøl; Serena Tonstad; Margo Schleman; Susa 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 122 KB

Apolipoprotein B/A-I and total cholester

Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein

✍ P. J. W. H. Kappelle; R. T. Gansevoort; J. L. Hillege; B. H. R. Wolffenbuttel; R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Erythrocyte sedimentation rate and C-rea

Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: A prospective follow-up study

✍ Fabrizio Cantini; Carlo Salvarani; Ignazio Olivieri; Luigi Macchioni; Andrea Ran 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Baseline Characteristics of Participants

Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

✍ Paul M. Ridker; Francisco A.H. Fonseca; Jacques Genest; Antonio M. Gotto; John J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 119 KB